Peyronie Disease Clinical Trial
— FRAPEYQUESTOfficial title:
French Translation and Validation of the PEYronie's Disease QUESTionnaire
This study is a prospective cohort dedicated to peyronie's disease. The aim is to validate the french translation of the peyronie's disease questionnaire. The primary endpoint is the response rate to the questionnaire.
| Status | Recruiting |
| Enrollment | 30 |
| Est. completion date | March 2025 |
| Est. primary completion date | March 2024 |
| Accepts healthy volunteers | No |
| Gender | Male |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Adult patient with Peyronie's Disease clinically diagnosed during a consultation, with palpation of at least one plaque Exclusion Criteria: - Patient refusing to participate - Patient with difficulties in understanding the French language. - Protected persons referred to in articles L.1121-6 to L.1121-8 of the public health code |
| Country | Name | City | State |
|---|---|---|---|
| France | Toulouse Hospital | Toulouse |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Toulouse |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Rate of responses | Response rate to the online questionnaire. | Day 0 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03774264 -
Treatment Response to Xiaflex for Men With Peyronie's Disease
|
||
| Recruiting |
NCT05777031 -
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease
|
Phase 4 | |
| Active, not recruiting |
NCT05871177 -
Safety and Efficacy of Intralesional HiLow Hyaluronic Acid in the Treatment of Peyronie's Disease (PD)
|
N/A | |
| Recruiting |
NCT04512287 -
PRP for Treatment of Peyronie's Disease
|
Phase 2 | |
| Withdrawn |
NCT05646602 -
Focused Shock Wave Therapy Outcomes in Peyronie's Disease and Erectile Dysfunction
|
N/A | |
| Recruiting |
NCT03530540 -
Low-Intensity Extracorporeal Shockwave Therapy and Vacuum Erectile Device as a Treatment for Peyronies Disease.
|
N/A | |
| Completed |
NCT04052217 -
Does Size Matter: A Single Case Experimental Design of Limiting the Depth of Penetration During Intercourse
|
N/A | |
| Recruiting |
NCT06303661 -
Non-ablative Radiofrequency and Low Intensity Shock Wave Therapy in Fibrotic Plaque in Men With Peyronie's Disease
|
N/A | |
| Recruiting |
NCT06065436 -
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
|
N/A | |
| Recruiting |
NCT05316714 -
Novel Nanofat Regenerative Surgical Technique for Peyronies' Disease Treatment
|
N/A | |
| Completed |
NCT04370652 -
Medical Treatment of Peyronie's Disease With Collagenase Clostridium Histolyticum
|
||
| Active, not recruiting |
NCT05480683 -
Pelvic CT With Agatston Calcium Score for Peyronie Disease
|
N/A | |
| Recruiting |
NCT04821115 -
Safety and Efficacy of Low-intensity Shockwave Therapy for Peyronie's Disease
|
N/A |